JP2007513127A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513127A5
JP2007513127A5 JP2006541996A JP2006541996A JP2007513127A5 JP 2007513127 A5 JP2007513127 A5 JP 2007513127A5 JP 2006541996 A JP2006541996 A JP 2006541996A JP 2006541996 A JP2006541996 A JP 2006541996A JP 2007513127 A5 JP2007513127 A5 JP 2007513127A5
Authority
JP
Japan
Prior art keywords
bladder
solid
formulation
semi
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006541996A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513127A (ja
JP5107578B2 (ja
Filing date
Publication date
Priority claimed from GBGB0328060.9A external-priority patent/GB0328060D0/en
Application filed filed Critical
Publication of JP2007513127A publication Critical patent/JP2007513127A/ja
Publication of JP2007513127A5 publication Critical patent/JP2007513127A5/ja
Application granted granted Critical
Publication of JP5107578B2 publication Critical patent/JP5107578B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006541996A 2003-12-04 2004-11-12 ボツリヌス毒素治療 Expired - Fee Related JP5107578B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0328060.9 2003-12-04
GBGB0328060.9A GB0328060D0 (en) 2003-12-04 2003-12-04 Botulinum toxin treatment
PCT/GB2004/004770 WO2005053733A1 (en) 2003-12-04 2004-11-12 Botulinum toxin treatment of spastic bladder

Publications (3)

Publication Number Publication Date
JP2007513127A JP2007513127A (ja) 2007-05-24
JP2007513127A5 true JP2007513127A5 (https=) 2007-12-27
JP5107578B2 JP5107578B2 (ja) 2012-12-26

Family

ID=29764527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541996A Expired - Fee Related JP5107578B2 (ja) 2003-12-04 2004-11-12 ボツリヌス毒素治療

Country Status (13)

Country Link
US (2) US20070275110A1 (https=)
EP (1) EP1691828B1 (https=)
JP (1) JP5107578B2 (https=)
AT (1) ATE475429T1 (https=)
CA (1) CA2547618C (https=)
DE (1) DE602004028403D1 (https=)
DK (1) DK1691828T3 (https=)
ES (1) ES2347151T3 (https=)
GB (1) GB0328060D0 (https=)
PL (1) PL1691828T3 (https=)
PT (1) PT1691828E (https=)
RU (1) RU2350348C2 (https=)
WO (1) WO2005053733A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
ES2509872T3 (es) 2005-03-03 2014-10-20 Allergan, Inc. Procedimientos para obtener una toxina clostrídica
US20090304747A1 (en) * 2006-05-16 2009-12-10 Mayo Foundation For Medical Education And Research Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
CA2678038C (en) 2007-02-15 2016-10-11 Allergan, Inc. Use of botulinum toxin and enzymes for treating bladder or prostate disorders, or hyperhydrosis
MX2010004502A (es) 2007-10-23 2010-06-17 Allergan Inc Metodos para tratar trastornos neurologicos urogenitales usando toxinas clostridiales modificadas.
US10471150B2 (en) 2010-01-20 2019-11-12 Urogen Pharma Ltd. Material and method for treating internal cavities
WO2011089604A2 (en) 2010-01-20 2011-07-28 Theracoat Ltd Material and method for treating internal cavities
US20130171122A1 (en) * 2011-12-29 2013-07-04 Allergan, Inc. Endopeptidase and neurotoxin combination treatment of bladder disorders
RU2635466C2 (ru) * 2012-04-08 2017-11-13 Теракоат Лтд Препараты термообратимого гидрогеля для применения при лечении нарушений уротелия
JP2017532301A (ja) * 2014-09-24 2017-11-02 ウェルズリー ファーマスーティカルズ、エルエルシー 膀胱痙攣を低減するための医薬製剤およびその使用の方法
RU2605624C1 (ru) * 2015-11-23 2016-12-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный педиатрический медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПбГПМУ Минздрава России) Способ лечения детрузорной гиперактивности
KR102480965B1 (ko) 2016-09-13 2022-12-26 알레간 인코포레이티드 안정화된 비단백질 클로스트리듐 독소 조성물
TWI810228B (zh) 2017-12-20 2023-08-01 英商艾普森生物製藥有限公司 自主神經系統障礙之治療
CA3201129A1 (en) 2020-12-11 2022-06-16 Yulia HIONIDI Material and method for treating cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236956A (en) * 1988-11-04 1993-08-17 Kabi Pharmacia Aktiebolag Compounds for the treatment of urinary incontinence
SE8804003D0 (sv) * 1988-11-04 1988-11-04 Pharmacia Ab Compounds for the treatment of urinary incontinence
JPH0564661A (ja) * 1991-09-09 1993-03-19 Olympus Optical Co Ltd 体腔内挿入具
US5437291A (en) * 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US5749845A (en) 1995-01-25 1998-05-12 Iotek, Inc. Delivering an agent to an organ
KR100544060B1 (ko) * 1997-07-15 2006-01-23 더 리젠트스 오브 더 유니버시티 오브 콜로라도 비뇨기과학 및 관련 부전증을 치료하기 위한 신경독요법의 용도
US6630570B1 (en) * 1999-04-09 2003-10-07 Insitut für Diagnostikforschung GmbH Short-chain peptide-dye conjugates as contrast media for optical diagnosis
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
US6579847B1 (en) * 2000-05-01 2003-06-17 Imarx Therapeutics Inc. Method and apparatus for vascular neuromuscular blockade
US6306423B1 (en) * 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6638246B1 (en) * 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
US20020099356A1 (en) * 2001-01-19 2002-07-25 Unger Evan C. Transmembrane transport apparatus and method
DK1411978T3 (da) * 2001-07-27 2009-01-05 Univ Louisiana State Botulinum-toksin ved behandlingen eller forebyggelsen af acne
AU2002323151A1 (en) * 2001-08-13 2003-03-03 University Of Pittsburgh Application of lipid vehicles and use for drug delivery
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
US20040067235A1 (en) * 2002-07-29 2004-04-08 Rajiv Doshi Methods for the use of neurotoxin in the treatment of urologic disorders

Similar Documents

Publication Publication Date Title
US12268745B2 (en) Material and method for treating internal cavities
JP2007513127A5 (https=)
ES2821098T3 (es) Preparaciones de hidrogel térmico reversible para su uso en el tratamiento de trastornos del urotelio
US10039832B2 (en) Material and method for treating internal cavities
US7459430B2 (en) Methods of using ziconotide to treat overactive bladder
EP2734187B1 (en) Materials and method for treating internal body cavities
JPH06503982A (ja) 泌尿器管感染症又は他の疾患の自己管理治療に使用可能であり、尿道プラグとしても使用可能である器具の使用方法及びその取出可能な器具
CN100355419C (zh) 治疗膀胱过度活动的药物
ITTO960427A1 (it) Forma di dosaggio comprendente ossibutinina
US6464670B1 (en) Method of delivering therapeutic agents to the urethra and an urethral suppository
WO2003004022A1 (es) Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria
RU2006123561A (ru) Лечение с применением ботулинического токсина
JP2021532155A (ja) トロスピウムを使用した過活動膀胱の治療方法
CN107224663B (zh) 一种泌尿外科用尿道给药器
US20150119467A1 (en) Methods for treatment of pelvic pain and/or comorbid conditions
US7223754B2 (en) Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
HK40061485A (en) Oxybutynin for intravesical application
CN1426818A (zh) 膀胱漂浮缓释药剂
Kuo Type 1 Detrusor Sphincter Dyssynergia in a Man with a Spinal Cord Injury